Clinically Relevant Adverse Effects

- Creatinine kinase of greater than ten times the upper limit of normal

- Severe myopathy

- Rhabdomyolysis

- AST or ALT elevations of greater than three times the upper limit of normal

- Renal failure

Rare adverse effects include diabetes mellitus, hematuria, proteinuria, and hypersensitivity.

Other reported symptomatic adverse effects include headache, dizziness, nausea, constipation, interstitial cystitis, arthralgia, and weakness.

Drug-Drug Interactions:

- The following medications may enhance the myopathic effect of rosuvastatin: acipimox, bezafibrate, ciprofibrate, colchicine, daptomycin, fenofibrate, fusidic acid, gemfibrozil, niacin, niacinamide, raltegravir, red yeast rice, rupatadine.

- The following medications may decrease the serum concentration of rosuvastatin: antacids, apalutamide, elagolix, eslicarbazepine.

- The following medications may increase the serum concentrations of rosuvastatin: asunaprevir, clopidogrel, cobicistat, cyclosporine, daclatasvir, dasabuvir, dronedarone, elbasvir, eltrombopag, eluxadoline, fostamatinib, glecaprevir, pibrentasvir, grazoprevir, itraconazole, ledipasvir, letermovir, ombitasvir, paritaprevir, ritonavir, osimertinib, protease inhibitors, simeprevir, teriflunomide, velpatasvir, voxilaprevir.